Ganoderma in breast cancer

The effect of eight periodic exercises and Ganoderma capsule mushroom consumption on oxidant/antioxidant factors in women undergoing chemotherapy with breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250205064652N1

Enrollment

Registered

2025-02-26

Start date

2025-03-02

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of nipple and areola

Interventions

Intervention 1: Control group: 15 patients, not receiving ganoderma mushroom in the amount of 1.6 grams daily, no aerobic exercise on a treadmil for 8 weeks, three sessions per week and 60 minutes per

Eligibility

Sex/Gender

Female

Age

35 Years to 55 Years

Inclusion criteria

Inclusion criteria: Gone through stages 1 to 3 of breast cancer The patients are currently undergoing chemotherapy They are mostly postmenopausal and have not experienced any menstrual period for 12 months before the beginning of the research

Exclusion criteria

Exclusion criteria: Radiotherapy Any kind of heart disorders Smoking Physical problems such as orthopedic and brain-nervous problems that prevent exercise Exercise before the beginning of the research exercises Metastatic cancer Drinking alcohol

Design outcomes

Primary

Measure	Time frame
Micro Ribonucleic acid 21. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Real time Polymerase chain reaction.;Micro Ribonucleic acid 34. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Real time Polymerase chain reaction.;Micro Ribonucleic acid 155. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Real time Polymerase chain reaction.;Superoxide Dismutase. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Enzyme-Linked Immunosorbent Assay.;Glutathione Peroxidase. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Enzyme-Linked Immunosorbent Assay.;Malondialdehyde. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Enzyme-Linked Immunosorbent Assay.	—

Measure

Time frame

Micro Ribonucleic acid 21. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Real time Polymerase chain reaction.;Micro Ribonucleic acid 34. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Real time Polymerase chain reaction.;Micro Ribonucleic acid 155. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Real time Polymerase chain reaction.;Superoxide Dismutase. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Enzyme-Linked Immunosorbent Assay.;Glutathione Peroxidase. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Enzyme-Linked Immunosorbent Assay.;Malondialdehyde. Timepoint: 48 hours before the first training session and 48 hours after the last training session. Method of measurement: Enzyme-Linked Immunosorbent Assay.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Adineh

Khoram-Abad University of Medical Sciences

ahmadadineh48@gmail.com+98 66 3312 0242

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026